Cover Image
市場調查報告書

癌症診斷設備的全球市場:2016∼2020年

Global Cancer Diagnostics Device Market 2016-2020

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 361492
出版日期 內容資訊 英文 67 Pages
訂單完成後即時交付
價格
Back to Top
癌症診斷設備的全球市場:2016∼2020年 Global Cancer Diagnostics Device Market 2016-2020
出版日期: 2016年06月13日 內容資訊: 英文 67 Pages
簡介

微陣列、次世代定序、質譜分析、自動DNA定序等先進的技術開發,打開著癌症生物標記的新門扉。這些技術,可偵測基因表現和癌症細胞的遺傳基因結構的異常。再加上從腫瘤的組織樣品,可分析DNA、RNA、染色體的變化。全球癌症診斷設備市場,預計2016∼2020年,以CAG18.07%擴大。

本報告提供全球癌症診斷設備市場現狀與2020年的預測,市場規模與銷售趨勢,彙整主要供應商的競爭環境與簡介。

第1章 摘要整理

第2章 本報告的範圍

第3章 市場調查方法

第4章 簡介

第5章 癌症統計

第6章 市場情況

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第7章 與償付補償:概要

  • 目前方案:診斷檢驗的評估
  • 美國的償付結構
  • EU的償付結構

第8章 癌症診斷設備:價格方案

第9章 癌症診斷設備的各產品市場區隔

第10章 癌症診斷設備的各癌症類型市場區隔

  • 肺癌
  • 乳癌
  • 大腸癌
  • 前列腺癌
  • 子宮頸癌

第11章 癌症診斷設備的各地區市場區隔

  • 南北美洲
  • 歐洲、中東、非洲
  • 亞太地區

第12章 癌症診斷設備的推動市場的要素

  • 癌症的罹患率
  • 藥物研發及開發新藥的降低成本的需求
  • 個人化醫療的需求
  • 技術進步
  • 著重新興國家

第13章 促進要素的影響

第14章 癌症診斷設備市場課題

第15章 促進要素與課題的影響

第16章 癌症診斷設備市場趨勢

第17章 供應商環境

  • 競爭模式
  • 主要消息
  • M&A

第18章 主要供應商分析

  • Abbott Diagnostics
  • Agilent Technologies
  • BD
  • bioMerieux
  • Qiagen
  • Roche Diagnostics
  • 其他值得注意的供應商

第19章 附錄

第20章 關於Technavio

目錄
Product Code: IRTNTR9265

About the Cancer Diagnostic Devices Market

An increase in any particular internal and external factor can lead to cancer. Currently, the demand for cancer therapy and research in complex molecular tumor diagnostics is high. Researchers are using automated solutions to isolate genetic materials from small tissue samples. The complex genetic analysis of samples using next-generation sequencing technologies helps researchers analyze the individual and relevant pattern of genetic changes in tumor tissues, helping in determining the most effective treatment options.

The development of sophisticated technologies such as microarray, next-generation sequencing, mass spectrometry, automated DNA sequencing, fluorescence in-situ hybridization, and comparative genomic hybridization has opened new avenues for cancer biomarkers. These technologies are capable of detecting abnormalities in the gene expression and the genetic structure of cancer cells. In addition, these technologies can analyze changes in the DNA, RNA, and chromosomes from tissue samples of a tumor.

Technavio's analysts forecast the global cancer diagnostics devices market to grow at a CAGR of 18.07% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global cancer diagnostics devices market for 2016-2020 To calculate the market size, we consider revenue generated from the sales of molecular and companion cancer diagnostic devices.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Cancer Diagnostics Devices Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Abbott Diagnostics
  • Agilent Technologies
  • BD
  • bioMerieux
  • Qiagen
  • Roche Diagnostics

Other Prominent Vendors

  • Affymetrix
  • Ambry Genetics
  • Annoroad
  • Aviva Biosciences
  • Biochain
  • Bio-Rad
  • Cancer Genetics
  • Cepheid
  • CompanionDx
  • DiagnoCure
  • Epic Sciences
  • Epigenomics
  • Genomic Health
  • HalioDX
  • Hologic
  • Illumina
  • Myriad Genetics
  • Thermo Fisher Scientific
  • Ventana Medical Systems
  • Vysis

Market driver

  • Demand for personalized medicines
  • For a full, detailed list, view our report

Market challenge

  • High cost of developing companion diagnostics
  • For a full, detailed list, view our report

Market trend

  • Demand for personalized medicines
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Cancer statistics

PART 06: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 07: Reimbursement and coverage: An overview

  • Current scenario: Validating diagnostic tests
  • Reimbursement structure in US
  • Reimbursement structure in EU

PART 08: Cancer diagnostic devices: Pricing scenario

PART 09: Market segmentation by product

  • Global companion cancer diagnostic devices market
  • Global molecular cancer diagnostic devices market

PART 10: Market segmentation by cancer type

  • Lung cancer
  • Breast cancer
  • Colorectal cancer
  • Prostate cancer
  • Cervical cancer

PART 11: Geographical segmentation

  • Cancer diagnostic devices market in Americas
  • Cancer diagnostic devices market in EMEA
  • Cancer diagnostic devices market in APAC

PART 12: Market drivers

  • Prevalence of cancer
  • Need for cost-cutting in drug discovery and development
  • Demand for personalized medicines
  • Advances in technology
  • Focus on emerging countries

PART 13: Impact of drivers

PART 14: Market challenges

  • Unfavorable reimbursement scenario
  • High cost of developing companion diagnostics
  • Stringent regulatory framework
  • Lack of skilled personnel

PART 15: Impact of drivers and challenges

PART 16: Market trends

  • Adoption of various strategies
  • Increase in R&D
  • Product approvals and launches

PART 17: Vendor landscape

  • Competitive scenario
  • Keys news
  • M&A

PART 18: Key vendors

  • Abbott Diagnostics
  • Agilent Technologies
  • BD
  • bioMerieux
  • Qiagen
  • Roche Diagnostics
  • Other prominent vendors

PART 19: Appendix

  • List of abbreviations

PART 20: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Prevalent cancer types worldwide 2012
  • Exhibit 03: Top countries with highest cancer rate worldwide 2012
  • Exhibit 04: Cancer statistics by gender 2012
  • Exhibit 05: Global cancer diagnostic devices market 2015-2020 ($ billions)
  • Exhibit 06: Five forces analysis
  • Exhibit 07: Reimbursement perspectives of healthcare entities
  • Exhibit 08: Factors influencing cost of cancer diagnostic devices
  • Exhibit 09: Global cancer diagnostic devices market segmentation by product
  • Exhibit 10: Global companion cancer diagnostic devices market 2015-2020 ($ millions)
  • Exhibit 11: Global molecular cancer diagnostic devices market 2015-2020 ($ billions)
  • Exhibit 12: Global cancer diagnostic devices market segmentation by cancer type 2015
  • Exhibit 13: Cancer types and associated diagnosis methods
  • Exhibit 14: Global cancer diagnostic devices market segmentation by geography 2015
  • Exhibit 15: Global cancer diagnostic devices market segmentation by geography 2020
  • Exhibit 16: Global cancer diagnostic devices market segmentation by geography 2015-2020 ($ millions)
  • Exhibit 17: Global cancer diagnostic devices market segmentation by geography 2015-2020
  • Exhibit 18: Cancer diagnostic devices market in Americas 2015-2020 ($ billions)
  • Exhibit 19: Cancer diagnostic devices market in EMEA 2015-2020 ($ millions)
  • Exhibit 20: Cancer diagnostic devices market in APAC 2015-2020 ($ millions)
  • Exhibit 21: Impact of drivers
  • Exhibit 22: Impact of drivers and challenges
  • Exhibit 23: Abbott Diagnostics: Product portfolio
  • Exhibit 24: Abbott Diagnostics: Key takeaways
  • Exhibit 25: Agilent Technologies: Product portfolio
  • Exhibit 26: Agilent Technologies: Revenue of diagnostics and genomics segment 2013-2015 ($ millions)
  • Exhibit 27: Agilent Technologies: Key takeaways
  • Exhibit 28: BD: Product portfolio
  • Exhibit 29: BD: Revenue of life sciences segment 2013-2015 ($ billions)
  • Exhibit 30: BD: Key takeaways
  • Exhibit 31: bioMerieux: Product portfolio
  • Exhibit 32: bioMerieux: Key takeaways
  • Exhibit 33: Qiagen: Product portfolio
  • Exhibit 34: Qiagen: Revenue of consumable and related products 2013-2015 ($ billions)
  • Exhibit 35: Qiagen: Key takeaways
  • Exhibit 36: Roche Diagnostics: Product portfolio
  • Exhibit 37: Roche Diagnostics: Revenue of molecular diagnostics segment 2013-2015 ($ billions)
  • Exhibit 38: Roche Diagnostics: Key takeaways
  • Exhibit 39: Other prominent vendors
Back to Top